Post by Novotech

Clinical development is no longer a linear process. As therapies become more complex, getting the clinical development strategy right is just as important as moving quickly. If you're attending BIO Asia Taiwan 2026, visit the Novotech team at Booth M509 to discuss your clinical development strategy from early-phase planning to APAC expansion and global development. Hear from Daniela Caiazza, PhD, Vice President, Clinical Services and General Manager, ANZ, as she presents Australia: A Go-To Destination for Clinical Trials, examining how Australia's regulatory environment, funding incentives, and clinical research ecosystem support faster early development and global clinical strategies. #BioAsiaTaiwan #ClinicalTrials #Biotech #DrugDevelopment